196 related articles for article (PubMed ID: 35328741)
1. Systematic Discovery of FBXW7-Binding Phosphodegrons Highlights Mitogen-Activated Protein Kinases as Important Regulators of Intracellular Protein Levels.
Singh N; Zeke A; Reményi A
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328741
[TBL] [Abstract][Full Text] [Related]
2. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
3. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin ligase FBXW7 targets the centriolar assembly protein HsSAS-6 for degradation and thereby regulates centriole duplication.
Badarudeen B; Gupta R; Nair SV; Chandrasekharan A; Manna TK
J Biol Chem; 2020 Apr; 295(14):4428-4437. PubMed ID: 32086376
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer.
Zhang MX; Wang H; Sun GP
Cell Biol Int; 2020 Sep; 44(9):1900-1910. PubMed ID: 32437091
[TBL] [Abstract][Full Text] [Related]
6. Regulation of BRAF protein stability by a negative feedback loop involving the MEK-ERK pathway but not the FBXW7 tumour suppressor.
Hernandez MA; Patel B; Hey F; Giblett S; Davis H; Pritchard C
Cell Signal; 2016 Jun; 28(6):561-71. PubMed ID: 26898828
[TBL] [Abstract][Full Text] [Related]
7. Degradation of the endoplasmic reticulum-anchored transcription factor MyRF by the ubiquitin ligase SCF
Nakayama S; Yumimoto K; Kawamura A; Nakayama KI
J Biol Chem; 2018 Apr; 293(15):5705-5714. PubMed ID: 29472293
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7.
Boretto M; Geurts MH; Gandhi S; Ma Z; Staliarova N; Celotti M; Lim S; He GW; Millen R; Driehuis E; Begthel H; Smabers L; Roodhart J; van Es J; Wu W; Clevers H
Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2309902121. PubMed ID: 38483988
[TBL] [Abstract][Full Text] [Related]
9. CRL2
Motomura S; Yumimoto K; Tomonaga T; Nakayama KI
Oncogene; 2024 Jun; 43(25):1917-1929. PubMed ID: 38698266
[TBL] [Abstract][Full Text] [Related]
10. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
Koo J; Wu X; Mao Z; Khuri FR; Sun SY
J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
[TBL] [Abstract][Full Text] [Related]
11. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
[TBL] [Abstract][Full Text] [Related]
12. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
[TBL] [Abstract][Full Text] [Related]
13. FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells.
An HJ; Lee CJ; Lee GE; Choi Y; Jeung D; Chen W; Lee HS; Kang HC; Lee JY; Kim DJ; Choi JS; Cho ES; Choi JS; Cho YY
Exp Mol Med; 2022 Jan; 54(1):35-46. PubMed ID: 35022544
[TBL] [Abstract][Full Text] [Related]
14. FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2.
Jiménez-Izquierdo R; Morrugares R; Suanes-Cobos L; Correa-Sáez A; Garrido-Rodríguez M; Cerero-Tejero L; Khan OM; de la Luna S; Sancho R; Calzado MA
Cell Death Dis; 2023 Mar; 14(3):202. PubMed ID: 36934104
[TBL] [Abstract][Full Text] [Related]
15. GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.
Pérez-Benavente B; García JL; Rodríguez MS; Pineda-Lucena A; Piechaczyk M; Font de Mora J; Farràs R
Oncogene; 2013 Apr; 32(17):2189-99. PubMed ID: 22710716
[TBL] [Abstract][Full Text] [Related]
16. The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.
Xie CM; Tan M; Lin XT; Wu D; Jiang Y; Tan Y; Li H; Ma Y; Xiong X; Sun Y
Cell Rep; 2019 Mar; 26(11):3037-3050.e4. PubMed ID: 30865892
[TBL] [Abstract][Full Text] [Related]
17. The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development.
de la Cova CC
Cells; 2023 Aug; 12(17):. PubMed ID: 37681873
[TBL] [Abstract][Full Text] [Related]
18. The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs.
Liu N; Li H; Li S; Shen M; Xiao N; Chen Y; Wang Y; Wang W; Wang R; Wang Q; Sun J; Wang P
J Biol Chem; 2010 Jun; 285(24):18858-67. PubMed ID: 20388706
[TBL] [Abstract][Full Text] [Related]
19. FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.
Wang R; Wang Y; Liu N; Ren C; Jiang C; Zhang K; Yu S; Chen Y; Tang H; Deng Q; Fu C; Wang Y; Li R; Liu M; Pan W; Wang P
Cell Res; 2013 Jun; 23(6):803-19. PubMed ID: 23507969
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
